“Conspiracy Theory”: Foundations of a Weaponized

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28 Bhawks #8006
103
“Conspiracy Theory”: Foundations of a Weaponized Term

Hawks favorite lying term to diffuse critics, only he is not conspiratorial, and that is the lie.

https://www.globalresearch.ca/conspiracy-theo...rm/5319708

First published by Global Research in 2013, this pathbreaking analysis by Professor James Tracy shows how the term “conspiracy theory” is being used to label critical analysis and dissenting viewpoints.

“Conspiracy theory” is a term that at once strikes fear and anxiety in the hearts of most every public figure, particularly journalists and academics. Since the 1960s the label has become a disciplinary device that has been overwhelmingly effective in defining certain events off limits to inquiry or debate. Especially in the United States raising legitimate questions about dubious official narratives destined to inform public opinion (and thereby public policy) is a major thought crime that must be cauterized from the public psyche at all costs.

Conspiracy theory’s acutely negative connotations may be traced to liberal historian Richard Hofstadter’s well-known fusillades against the “New Right.” Yet it was the Central Intelligence Agency that likely played the greatest role in effectively “weaponizing” the term. In the groundswell of public skepticism toward the Warren Commission’s findings on the assassination of President John F. Kennedy, the CIA sent a detailed directive to all of its bureaus. Titled “Countering Criticism of the Warren Commission Report,” the dispatch played a definitive role in making the “conspiracy theory” term a weapon to be wielded against almost any individual or group calling the government’s increasingly clandestine programs and activities into question.

This important memorandum and its broad implications for American politics and public discourse are detailed in a forthcoming book by Florida State University political scientist Lance de-Haven-Smith, Conspiracy Theory in America. Dr. de-Haven-Smith devised the state crimes against democracy concept to interpret and explain potential government complicity in events such as the Gulf of Tonkin incident, the major political assassinations of the 1960s, and 9/11.

“CIA Document 1035-960” was released in response to a 1976 FOIA request by the New York Times. The directive is especially significant because it outlines the CIA’s concern regarding “the whole reputation of the American government” vis-à-vis the Warren Commission Report. The agency was especially interested in maintaining its own image and role as it “contributed information to the [Warren] investigation.”

The memorandum lays out a detailed series of actions and techniques for “countering and discrediting the claims of the conspiracy theorists, so as to inhibit the circulation of such claims in other countries.” For example, approaching “friendly elite contacts (especially politicians and editors)” to remind them of the Warren Commission’s integrity and soundness should be prioritized. “ he charges of the critics are without serious foundation,” the document reads, and “further speculative discussion only plays in to the hands of the [Communist] opposition.”

The agency also directed its members “ o employ propaganda assets to [negate] and refute the attacks of the critics. Book reviews and feature articles are particularly appropriate for this purpose.”

1035-960 further delineates specific techniques for countering “conspiratorial” arguments centering on the Warren Commission’s findings. Such responses and their coupling with the pejorative label have been routinely wheeled out in various guises by corporate media outlets, commentators and political leaders to this day against those demanding truth and accountability about momentous public events.

No significant new evidence has emerged which the [Warren] Commission did not consider.
Critics usually overvalue particular items and ignore others.
Conspiracy on the large scale often suggested would be impossible to conceal in the United States.
Critics have often been enticed by a form of intellectual pride: they light on some theory and fall in love with it.
Oswald would not have been any sensible person’s choice for a co-conspirator.
Such vague accusations as that “more than ten people have died mysteriously” [during the Warren Commission’s inquiry] can always be explained in some natural way e.g.: the individuals concerned have for the most part died of natural causes.
Today more so than ever news media personalities and commentators occupy powerful positions for initiating propaganda activities closely resembling those set out in 1035-960 against anyone who might question state-sanctioned narratives of controversial and poorly understood occurrences. Indeed, as the motives and methods encompassed in the document have become fully internalized by intellectual workers and operationalized through such media, the almost uniform public acceptance of official accounts concerning unresolved events such as the Oklahoma City Murrah Federal Building bombing, 9/11, and most recently the Sandy Hook Elementary School massacre, is largely guaranteed.

The effect on academic and journalistic inquiry into ambiguous and unexplained events that may in turn mobilize public inquiry, debate and action has been dramatic and far-reaching. One need only look to the rising police state and evisceration of civil liberties and constitutional protections as evidence of how this set of subtle and deceptive intimidation tactics has profoundly encumbered the potential for future independent self-determination and civic empowerment.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading